MAPT and supranuclear palsy, progressive, 1: Histopathological differences observed within the brains of PD and PSP patients have suggested that tau protein, which is found to be phosphorylated and aggregated in NFTs in PSP patients [38], could represent a valuable protein to discriminate PSP from PD.